Stake Announced

Incyte stake in Genesis Molecular AI

US$40m consideration

Announced 3 Jun 2026

Advisers

Genesis Molecular AI

Target

Not disclosed

Incyte

Acquirer

Target
Genesis Molecular AI
Acquirer
Incyte
Target based in
United States (unverified)
Buyer based in
United States
Structure
Minority stake
Sector
AI
Tags
AI, Drug Development, Biotech

In the league tables

Similar deals

All AI deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.